In conclusion, our results showed that urinary CD80 was not a reliable differential diagnostic marker between MCD in relapse and FSGS or other kidney diseases, including inherited kidney diseases, in contrast to previous reports. This evidence concerns the gene CD80 and focal segmental glomerulosclerosis.